Medical Devices: Page 2
-
Profile
Hemorrhage can be a serious problem after pregnancy. Here’s how one medtech founder is tackling it
Kelsey Mayo, CEO of Armor Medical, received the grand prize in MedTech Innovator’s pitch competition for a wearable technology to detect serious blood loss early.
By Elise Reuter • Oct. 23, 2025 -
Solventum hires Heather Knight from Baxter to fill new C-suite post
Chris Barry, group president of medsurg at Solventum, is leaving the company at the end of the year in connection with Knight’s arrival.
By Nick Paul Taylor • Oct. 23, 2025 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
CoMind raises $102.5M to develop non-invasive bedside brain monitor
The company is enrolling patients in an early feasibility trial as part of plans to launch its device in 2027.
By Nick Paul Taylor • Updated Oct. 28, 2025 -
Intuitive Surgical reports strong Q3 as da Vinci procedures climb
Intuitive Surgical’s shares surged nearly 15% early Wednesday after the robot maker’s third-quarter sales and earnings topped analysts’ expectations.
By Susan Kelly • Oct. 22, 2025 -
AHA urges tariff exceptions for certain PPE, medical devices
The American Hospital Association warned future tariffs arising from the Trump administration’s Section 232 investigation could disrupt access to an array of tools and personal protective equipment.
By Susan Kelly • Oct. 21, 2025 -
Hologic to go private for up to $18.3B
Funds managed by Blackstone and TPG plan to acquire the medtech firm for up to $79 per share.
By Elise Reuter • Oct. 21, 2025 -
MDMA warns Section 232 tariffs could hurt US medtech manufacturing
The trade group said levies would “needlessly disrupt a globally integrated industry that already meets domestic demand.”
By Nick Paul Taylor • Oct. 21, 2025 -
Q&A
Biolinq’s Jared Tangney on making CGMs unintimidating
The chief technology officer and co-founder explained the technology and design choices that went into Biolinq’s device, which he hopes will be easier to use than other glucose monitors.
By Elise Reuter • Oct. 20, 2025 -
Dexcom faces proposed class action suit over G7 CGM problems
The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.
By Elise Reuter • Oct. 20, 2025 -
AdvaMed calls for series of trade actions in response to Section 232 probe
In comments submitted to the Trump administration on its medical equipment investigation, the industry group recommended a tariff-free trading bloc with trusted countries among its proposals.
By Susan Kelly • Oct. 20, 2025 -
Ōura to pursue FDA clearance of blood pressure feature for smart ring
The company has received approval to validate and define the feature in a study that is scheduled to start this year.
By Nick Paul Taylor • Oct. 20, 2025 -
Boston Scientific to buy Nalu Medical for $533M
Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral nerves.
By Susan Kelly • Oct. 17, 2025 -
HistoSonics raises $250M to expand use of noninvasive cancer therapy
The company raised money from Bezos Expeditions, Thiel Bio and other investors to fund the commercial and clinical expansion of its technology.
By Nick Paul Taylor • Oct. 17, 2025 -
What J&J’s ortho spinoff means for the industry
Analysts expect that DePuy Synthes could become a stronger competitor as a standalone company.
By Elise Reuter • Oct. 16, 2025 -
BD CFO Chris DelOrefice leaving for new job
Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall Street consensus expectations.
By Susan Kelly • Oct. 16, 2025 -
To move or not to move? Manufacturers hesitant to nearshore before USMCA review
While some companies are using regional supply chains or leaning on tariff exemptions by maximizing compliance, others are frozen in place.
By Shefali Kapadia • Oct. 16, 2025 -
Abbott CEO: ‘We’re right on time’ to the PFA party
As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.
By Elise Reuter • Oct. 15, 2025 -
Stereotaxis teams with CardioFocus to develop robotic PFA system
Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ablation.
By Nick Paul Taylor • Oct. 15, 2025 -
5 AI takeaways from AdvaMed’s conference
Medical device firms discussed privacy, regulations and prioritizing projects as AI becomes more prevalent in the industry.
By Elise Reuter • Oct. 14, 2025 -
Cybersecurity triggers another recall of J&J’s Impella heart pump controller
While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious injury or death.
By Nick Paul Taylor • Oct. 14, 2025 -
Intuitive’s challengers continue to advance
Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their progress in this roundup of the latest developments in surgical robotics.
By Susan Kelly • Oct. 10, 2025 -
Zimmer launches 2 devices from $1.1B orthopedic takeover
After acquiring Paragon 28 earlier this year, Zimmer intends to maintain the foot and ankle specialist’s double-digit growth.
By Nick Paul Taylor • Oct. 10, 2025 -
Intuitive expands AI in Ion; Horizon performs first robotic cataract surgery
The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract surgery with its robotic system, and MMI began a neurosurgical study.
By Susan Kelly • Oct. 10, 2025 -
FDA’s presence at AdvaMed conference shrinks amid shutdown
Michelle Tarver, director of the Center for Devices and Radiological Health, and other center officials attended virtually as a government shutdown continues.
By Elise Reuter • Oct. 9, 2025 -
Medtronic begins study of Hugo robot in gynecology
With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on Intuitive Surgical in the U.S. robotic surgery market.
By Susan Kelly • Oct. 9, 2025